Ameritas Investment Partners’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $16.7K | Hold |
3,701
| – | – | ﹤0.01% | 2737 |
|
|
2025
Q1 | $16.4K | Hold |
3,701
| – | – | ﹤0.01% | 2638 |
|
|
2024
Q4 | $29K | Hold |
3,701
| – | – | ﹤0.01% | 2474 |
|
|
2024
Q3 | $48.7K | Hold |
3,701
| – | – | ﹤0.01% | 2206 |
|
|
2024
Q2 | $44.7K | Hold |
3,701
| – | – | ﹤0.01% | 2203 |
|
|
2024
Q1 | $60.2K | Buy |
3,701
+1,056
| +40% | +$17.2K | ﹤0.01% | 2043 |
|
|
2023
Q4 | $18K | Hold |
2,645
| – | – | ﹤0.01% | 2623 |
|
|
2023
Q3 | $14.4K | Hold |
2,645
| – | – | ﹤0.01% | 2683 |
|
|
2023
Q2 | $18K | Hold |
2,645
| – | – | ﹤0.01% | 2617 |
|
|
2023
Q1 | $13.3K | Hold |
2,645
| – | – | ﹤0.01% | 2621 |
|
|
2022
Q4 | $11.7K | Hold |
2,645
| – | – | ﹤0.01% | 2769 |
|
|
2022
Q3 | $38K | Hold |
2,645
| – | – | ﹤0.01% | 2182 |
|
|
2022
Q2 | $40K | Hold |
2,645
| – | – | ﹤0.01% | 2141 |
|
|
2022
Q1 | $31K | Hold |
2,645
| – | – | ﹤0.01% | 2353 |
|
|
2021
Q4 | $43K | Hold |
2,645
| – | – | ﹤0.01% | 2228 |
|
|
2021
Q3 | $75K | Hold |
2,645
| – | – | ﹤0.01% | 1871 |
|
|
2021
Q2 | $89K | Hold |
2,645
| – | – | ﹤0.01% | 1795 |
|
|
2021
Q1 | $80K | Hold |
2,645
| – | – | ﹤0.01% | 1786 |
|
|
2020
Q4 | $131K | Hold |
2,645
| – | – | 0.01% | 1411 |
|
|
2020
Q3 | $102K | Hold |
2,645
| – | – | ﹤0.01% | 1413 |
|
|
2020
Q2 | $114K | Buy |
2,645
+616
| +30% | +$26.6K | 0.01% | 1338 |
|
|
2020
Q1 | $53K | Hold |
2,029
| – | – | ﹤0.01% | 1625 |
|
|
2019
Q4 | $63K | Buy |
2,029
+257
| +15% | +$7.98K | ﹤0.01% | 1781 |
|
|
2019
Q3 | $46K | Hold |
1,772
| – | – | ﹤0.01% | 1931 |
|
|
2019
Q2 | $41K | Buy |
1,772
+1,197
| +208% | +$27.7K | ﹤0.01% | 2029 |
|
|
2019
Q1 | $15K | Hold |
575
| – | – | ﹤0.01% | 2537 |
|
|
2018
Q4 | $12K | Buy |
+575
| New | +$12K | ﹤0.01% | 2605 |
|